palmitoylethanolamide.com.au
HomeResearchRosanna 2016

Protective Effects of Ultramicronized Palmitoylethanolamide (PEA-um) in Myocardial Ischaemia and Reperfusion Injury in VIVO

Rosanna Di Paola, Marika Cordaro, Rosalia Crupi, Rosalba Siracusa, Michela Campolo, Giuseppe Bruschetta, Roberta Fusco, Pietro Pugliatti, Emanuela Esposito, Salvatore Cuzzocrea. Shock. 2016;46(2):202-13.

Laboratory studyOther animals

Design
Laboratory study
Subjects
Mice (wild-type and PPAR-alpha knockout) with myocardial ischaemia produced by 30 minutes of coronary artery occlusion followed by 2 hours of reperfusion
Dose used in the study
Ultramicronised PEA (PEA-um), 10 mg/kg, given 15 minutes after ischaemia onset and 1 hour after reperfusion
Duration
30 minutes of ischaemia plus 2 hours of reperfusion
What was measured
Heart tissue injury, neutrophil infiltration, adhesion molecules (ICAM-1, P-selectin), cytokines (TNF-alpha, IL-1beta), nitrotyrosine and PAR formation, NF-kB expression, and apoptosis markers (Fas-L, Bcl-2); comparison between normal mice and PPAR-alpha knockout mice

What the authors reported

PEA-um reduced heart tissue injury, neutrophil infiltration, adhesion molecule and cytokine levels, nitrotyrosine and PAR formation, NF-kB expression and apoptosis markers in normal mice. This protection was not seen in mice lacking the PPAR-alpha receptor, and ischaemia-reperfusion injury was worse in those knockout mice overall, pointing to a PPAR-alpha-dependent mechanism.

Limits of this study

A mouse model of surgically induced heart ischaemia and reperfusion; it cannot show effect in people. Funding and conflicts not stated in the abstract.

Source

PubMed 26844976 · doi:10.1097/SHK.0000000000000578

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.